Adolescent & Young Adult Research (AYAR)
@ The CORE Center
The Adolescent and Young Adult Research (AYAR) at the CORE Center is dedicated to HIV prevention and treatment research in adolescents and young adults in the Chicagoland area. The AYAR team also provides clinical services for adolescents and young adults throughout the Cook County Health & Hospitals System, including Stroger Hospital, the CORE Center, and the Austin, Fantus and Dr. Jorge Prieto Health Centers.
HIV Prevention Trials Network (HPTN) 083 Trial
The main purpose of this study is to try to find out if a new drug, called cabotegravir (CAB), is as safe and will work as well as Truvada (TDF/FTC) in protecting us from getting HIV. CAB is available in the form of a pill and as an injection (shot). Researchers do not yet know if this injectable drug will work to protect people from getting HIV. This is why we are doing this study.
Gilead Discover Trial
The main purpose of this study is to try to find out if a new drug, called emtricitabine and tenofovir alafenamide (F/TAF), is as safe and will work as well as Truvada (TDF/FTC) in protecting us from getting HIV. F/TAF is available in the form of a pill. Researchers do not yet know if this drug will work to protect people from getting HIV. This is why we are doing this study.
Adolescent Trials Network: iTech & Scale It Up
The AYAR @ CORE team is currently participating in two ATN trials networks including iTech and Scale It Up. The primary mission of the Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions is to conduct research aimed at the reduction of new HIV infections in youth & research aimed at the improvement in the proportions of youth achieving successive milestones across the HIV care continuum. ATN projects we will be running in Chicago include YouTHrive, Lynx, P3, Compare and Tailored Motivational Interviewing (TMI).